Canada Life’s Audentes Therapeutics, Inc BOLD Stock Holding History

Canada Life’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,508	Closed	-$149K	–	2789
2019 Q4	$149K	Hold	2,508	–	–	﹤0.01%	1991
2019 Q3	$71K	Sell	2,508 -2,218	-47%	-$75.7K	﹤0.01%	1025
2019 Q2	$179K	Hold	4,726	–	–	﹤0.01%	2055
2019 Q1	$184K	Hold	4,726	–	–	﹤0.01%	1898
2018 Q4	$97K	Buy	4,726 +2,315	+96%	+$59.7K	﹤0.01%	2160
2018 Q3	$96K	Hold	2,411	–	–	﹤0.01%	2206
2018 Q2	$92K	Hold	2,411	–	–	﹤0.01%	2217
2018 Q1	$73K	Hold	2,411	–	–	﹤0.01%	2270
2017 Q4	$75K	Buy	+2,411	New	+$66.2K	﹤0.01%	2259

Canada Life's BOLD Position: Q1 2020 in Review

Canada Life sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 2,508 shares — an estimated $149K sold.

Canada Life first reported a position in BOLD in Q4 2017 and held it in 9 quarters. The position peaked at $184K in Q1 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Canada Life reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Canada Life sold 2,508 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $149K.
Canada Life first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 9 quarters.
Canada Life's Audentes Therapeutics, Inc position peaked at $184K in Q1 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Canada Life's 13F filing for Q1 2020, filed 14 May 2020.